Understanding the Economics of Aphasia: Recent Findings from Speech and Language Research

Abstract

In recent years, stakeholders engaged in the study, treatment, and understanding of aphasia outcomes have emphasized the need for greater transparency regarding the economics of aphasia rehabilitation. Most notably, third-party payers and clinicians have a keen interest in understanding the resources used to treat aphasia, particularly the cost-effectiveness and value of aphasia treatments. In this article, we review the current literature related to the economic burden of aphasia and the cost and cost-effectiveness of aphasia treatments. To date, relatively few scholars have attempted to study the efficiency, scale, and scope related to the economics of aphasia and the cost-effectiveness of aphasia treatment. While studies of the cost-effectiveness of aphasia treatments have shown rehabilitative treatments conform to established quality and cost benchmarks, the continued progress and developments in the treatment of aphasia and measurement of clinical outcomes has left many areas unstudied. We highlight the need for greater emphasis on the cost-effectiveness of aphasia treatments in addition to the traditional focus on the efficacy of treatment outcomes.

Keywords

aphasia - economics - cost-effectiveness - value

Disclosures

The authors have no disclosures to report. This project was not associated with any funding.

Publikationsverlauf

Artikel online veröffentlicht:
20. Juli 2022

• References

• 1 Simmons-Mackie N. Aphasia in North America. 2018 . Accessed November 20, 2021 at: https://www.aphasiaaccess.org/white-papers/
• 2 Simmons-Mackie N, Kagan A. Application of the ICF in aphasia. Semin Speech Lang 2007; 28 (04) 244-253
• 3 Bullier B, Cassoudesalle H, Villain M. et al. New factors that affect quality of life in patients with aphasia. Ann Phys Rehabil Med 2020; 63 (01) 33-37
• 4 Ellis C, Peach RK. Life satisfaction and aphasia: an integrative review with recommendations for future research. Aphasiology 2017; 31 (06) 631-642
• 5 Ellis C, Phillips R, Hill T, Briley PM. Social network structure in young stroke survivors with aphasia: a case series report. Semin Speech Lang 2019; 40 (05) 359-369
• 6 Brady MC, Kelly H, Godwin J, Enderby P, Campbell P. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016; (06) CD000425
• 7 Ellis C, Simpson AN, Bonilha H, Mauldin PD, Simpson KN. The one-year attributable cost of poststroke aphasia. Stroke 2012; 43 (05) 1429-1431
• 8 van der Gaag A, Brooks R. Economic aspects of a therapy and support service for people with long-term stroke and aphasia. Int J Lang Commun Disord 2008; 43 (03) 233-244
• 9 Jordan N, Deutsch A. Why and how to demonstrate the value of rehabilitation services. Arch Phys Med Rehabil 2021:S0003-9993(21)01359-9
• 10 Palmer R, Witts H, Chater T. What speech and language therapy do community dwelling stroke survivors with aphasia receive in the UK?. PLoS One 2018; 13 (07) e0200096
• 11 Howard-Wilsher S, Irvine L, Fan H. et al. Systematic overview of economic evaluations of health-related rehabilitation. Disabil Health J 2016; 9 (01) 11-25
• 12 Krütli P, Rosemann T, Törnblom KY, Smieszek T. How to fairly allocate scarce medical resources: ethical argumentation under scrutiny by health professionals and lay people. PLoS One 2016; 11 (07) e0159086
• 13 Angelis A, Kanavos P, Montibeller G. Resource allocation and priority setting in health care: a multicriteria decision analysis problem of value. Glob Policy 2017; 8 (52) 76-83
• 14 American Economic Association. What is economics?. Accessed November 20, 2021; at: https://www.aeaweb.org/resources/students/what-is-economics 2021
• 15 Jacobs M, Ellis C. Aphasianomics: estimating the economic burden of poststroke aphasia in the United States. Aphasiology 2021; 1-14
• 16 Drummond M, Torrance G, O'Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed.. Oxford: Oxford Medical; 2005
• 17 Porter ME, Teisberg EO. Redefining Health Care: Creating Value-Based Competition on Results. Boston, MA: Harvard Business School Press; 2006
• 18 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
• 19 Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs 2005; 52 (05) 546-553
• 20 Ellis C, Hardy RY, Lindrooth RC. Greater healthcare utilization and costs among Black persons compared to White persons with aphasia in the North Carolina stroke belt. J Neurol Sci 2017; 376: 76-83
• 21 Ellis C, Peach R, Hardy RY, Lindrooth RC. The influence of race on SLP utilisation and costs among persons with aphasia. Aphasiology 2017; 31 (12) 1433-1440
• 22 Jamison DT, Breman JG, Measham AR. et al, eds. Priorities in Health. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2006 . Chapter 3, Cost-Effectiveness Analysis. Accessed November 20, 2021 at: https://www.ncbi.nlm.nih.gov/books/NBK10253/
• 23 Boyer N, Jordan N, Cherney LR. Implementation cost analysis of an intensive comprehensive aphasia program. Arch Phys Med Rehabil 2020:S0003-9993(20)31253-3
• 24 Palmer R, Enderby P, Cooper C. et al. Computer therapy compared with usual care for people with long-standing aphasia poststroke: a pilot randomized controlled trial. Stroke 2012; 43 (07) 1904-1911
• 25 Latimer NR, Dixon S, Palmer R. Cost-utility of self-managed computer therapy for people with aphasia. Int J Technol Assess Health Care 2013; 29 (04) 402-409
• 26 Ellis C, Lindrooth RC, Horner J. Retrospective cost-effectiveness analysis of treatments for aphasia: an approach using experimental data. Am J Speech Lang Pathol 2014; 23 (02) 186-195
• 27 Palmer R, Dimairo M, Cooper C. et al. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial. Lancet Neurol 2019; 18 (09) 821-833
• 28 Jacobs M, Briley PM, Wright HH, Ellis C. Marginal assessment of the cost and benefits of aphasia treatment: evidence from community-based telerehabilitation treatment for aphasia. J Telemed Telecare 2021; ; (published online ahead of print)
• 29 Jacobs M, Ellis C. Estimating the cost and value of functional changes in communication ability following telepractice treatment for aphasia. PLoS One 2021; 16 (09) e0257462
• 30 Latimer NR, Bhadhuri A, Alshreef A. et al. Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: an economic evaluation. Clin Rehabil 2021; 35 (05) 703-717
• 31 Liu Z, Huang J, Xu Y, Wu J, Tao J, Chen L. Cost-effectiveness of speech and language therapy plus scalp acupuncture versus speech and language therapy alone for community-based patients with Broca's aphasia after stroke: a post hoc analysis of data from a randomised controlled trial. BMJ Open 2021; 11 (09) e046609
• 32 Laxminarayan R, Chow J, Shahid-Salles SA. Intervention Cost-Effectiveness: Overview of Main Messages. In: Jamison DT, Breman JG, Measham AR. et al., eds. Disease Control Priorities in Developing Countries. 2nd ed.. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2006. . Chapter 2. Accessed November 20, 2021 at: https://www.ncbi.nlm.nih.gov/books/NBK11784/ Co-published by Oxford University Press, New York.
• 33 National Institute on Deafness and Other Communication Disorders. 2021 . 2017–2021 NIDCD Strategic Plan. Accessed November 20, 2021 at: https://www.nidcd.nih.gov/sites/default/files/Documents/NIDCD-StrategicPlan2017-508.pdf
• 34 Peach RK. Management of Acquired Language Disorders Associated with Attentional Impairment. In: Peach RK, Shapiro LP. eds. Cognition and Acquired Language Disorders. Mosby: 2012
• 35 Centers for Disease Control and Prevention. Economic evaluation overview. 2021 . Accessed November 20, 2021 at: https://www.cdc.gov/policy/polaris/economics/index.html
• 36 Centers for Disease Control and Prevention. Cost-effectiveness analysis. 2021 . Accessed November 20, 2021 at: https://www.cdc.gov/policy/polaris/economics/cost-effectiveness/index.html
• 37 Salomon JA. Quality Adjusted Life Year. International Encyclopedia of Public Health, 2nd ed. . 2017 . Accessed November 20, 2021 at: https://www.sciencedirect.com/topics/nursing-and-health-professions/quality-adjusted-life-year
• 38 Heller DJ, Coxson PG, Penko J. et al. Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke. Circulation 2017; 136 (12) 1087-1098